- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Reversing diabetes for heart and kidney health; MS and medical marijuana; ‘notice of exclusion’ due to fraud – Morning Medical Update
The top news stories in medicine today.
© meeboonstudio - stock.adobe.com
Diabetes, heart and kidney effects
Losing weight helps patients control type 2 diabetes, and even reverse it. That also means good news for the heart and kidneys, according to a new study. It is among the first to show reversing diabetes in turn has long-term effects on cardiovascular and kidney outcomes, according to an accompanying news release.
The U.S. Food and Drug Administration has recommended reclassifying marijuana from Schedule I of the Controlled Substances Act, to Schedule III, potentially opening up more testing, research and prescriptions. If that happens, there could be implications for primary care physicians. How are multiple sclerosis specialists using marijuana in medicine? This article explaining symptom management was the most read piece of 2023 in the International Journal of MS Care.
The U.S. Department of Health and Human Services Office of Inspector General issued a “notice of exclusion” barring Theranos Inc. founder and CEO Elizabeth Holmes from participating in federal health care programs for 90 years. Two years ago, Holmes was convicted of wire fraud and conspiracy to commit wire fraud against the blood testing company’s investors. Last year Holmes was sentenced to 11 years in prison and to pay $452 million in restitution.
